Introduction
============

Serotype 5 is one of more than 91 pneumococcal capsular serotypes ([@B14]) and is included in current pneumococcal conjugate vaccine formulations (13- and 10-valent) and the 23-valent polysaccharide vaccine. Like serotype 1, serotype 5 is one of a limited number of serotypes that are highly associated with invasive pneumococcal disease (IPD) and localized disease clusters compared to most other pneumococcal serotypes ([@B16]; [@B31]; [@B2]; [@B35]). Serotypes 1 and 5 were found to have the highest "invasive index" among pneumococci, based upon their relatively high propensity to be recovered from IPD rather than from carriage samples ([@B7]).

In a 2009 carriage study in Kenya ([@B8]; [@B10]) in an area with high pneumococcal carriage among adults (median age 32 years; 43.2 and 26.8% frequency for pneumococcal isolation from combined oropharyngeal and nasopharyngeal specimens from HIV-positive and HIV-negative adults, respectively), we found that a very high percentage of specimens negative for a pneumococcal-specific *lytA* PCR assay yielded pneumococcal serotype-specific PCR amplicons ([@B8]). The sequences of these amplicons were highly homologous to the serotype-specific pneumococcal counterparts leading us to speculate that it was likely that such strains expressed surface carbohydrates highly related to those expressed from different serotypes of pneumococci. For several of *wzy*-positive, *lytA*-negative specimens we were able to recover non-pneumococcal Mitis group streptococci, including strains that were positive for PCR assays ([@B27]; [@B29]) targeting *wzy5*, *wzy12F*, *wzy15A*, and *wzy33F.* We found that a high percentage of upper respiratory specimens from adults were positive for the serotype 5 specific *wzy5* gene when employing a conventional PCR assay ([@B27]) (32.3%; 51 of 158 specimens), even though we were unable to recover serotype 5 pneumococcal isolates from specimens taken from adults ([@B8]). Subsequently, employing standard culture methodology we readily isolated a *Streptococcus mitis* strain that was PCR-positive for the serotype 5-specific *wzy5* gene (strain KE67013 shown in Table [1](#T1){ref-type="table"}) from these specimens. In another carriage study performed in the United States during 2015--2016 in a population of older adults (age ≥ 65 years) with much lower pneumococcal carriage (1.2% by culture), we also found a relatively high number of *wzy5*-positive upper respiratory specimens from *lytA*-negative (indicative of pneumococcal-negative) specimens (11/395, 2.8%) and a single *wyz5*-positive from a less common *lytA*-positive specimen (1/53, 1.9%) ([@B21]). Importantly, our recent study ([@B21]) described the isolation of five independent *Streptococcus mitis* strains representing three unrelated clones that expressed a capsular serotype highly related to serotype 1 pneumococci as deduced from immunodiffusion experiments and opsonophagocytic killing (OPK) assays. What is most noteworthy from this study was that the frequency of carriage of capsular serotype 1 non-pneumococcal isolates within this elderly population was actually much higher than the carriage of serotype 1 pneumococci.

###### 

Non-pneumococcal strains carrying *cps* locus homologs of pneumococcal strains of known serotypes described in this manuscript.

                                                                     Capsular serology result   OPK activity of
  --------- ----------------------- --------------- ----- ---------- -------------------------- ----------------------------
  KE67013   2009 Kenya^a^           *S. mitis*      5     Adult OP   Serotype 5                 Specific killing of type 5
                                                                                                pneumococci
  US0049    2013 United States^b^   *S. oralis*     5     Adult OP   Serotype 5                 Not tested
  US0024    2013 United States^b^   *S. infantis*   5     Adult OP   Serotype 5                 Not tested
  US969j1   2013 United States^b^   *S. infantis*   5     Adult OP   Serotype 5                 Not tested
  KE67213   2009 Kenya^a^           *S. oralis*     12F   Adult OP   Serogroup 12               Not tested
  KE66813   2009 Kenya^a^           *S. oralis*     15A   Adult OP   No reactivity              Not tested
  KE66713   2009 Kenya^a^           *S. mitis*      18A   Child NP   Serotype 18A (weak)        Not tested
  KE66913   2009 Kenya^a^           *S. oralis*     33F   Adult OP   Serogroup 33 (weak)        Not tested

a

Isolation previously described (

Carvalho et al., 2013

); details of carriage study previously described (

Conklin et al., 2016

).

b

Isolation from carriage specimens carried out in this work from carriage specimens described in year 2015--2016 carriage study (

Lessa et al., 2018

).

c

OP = oropharyngeal swab specimen; NP = nasopharyngeal swab specimen. Only one specimen was from a child \<5 years of age

.

While, we were also unable to isolate serotype 5 pneumococci in the US study ([@B21]), we have subsequently isolated two distinct strains of *wzy5*-positive *S. infantis* and one *S. oralis* strain from *lytA*-negative specimens. Our genomic and serologic analysis of these four strains from three distinct Mitis group species that carry *cps5* loci recovered from upper respiratory specimens described in two previously described carriage studies ([@B8] and [@B10] for the single *S. mitis* strain; [@B21] for a single *S. oralis* strain and two *S. infantis* strains) extends recent descriptions of several *cps* loci from non-pneumococcal Mitis group streptococci that shared high genetic and antigenic relatedness to known pneumococcal serotypes ([@B34]). Here, we extend our recent work that demonstrated cross-species OPK activity of serotype 1 *S. mitis* antiserum against serotype 1 pneumococci ([@B21]), through demonstration of serotype-specific opsonic activity of *wzy5*-positive *S. mitis* antiserum against serotype 5 pneumococci. We also describe genomic and serologic features of four additional non-pneumococcal strains previously recovered in Kenya ([@B8]) that contain homologs of serogroup 12, 15, 18, and 33 pneumococcal *cps* loci.

The growing evidence of conserved capsular serotypes between the commensal Mitis group and pneumococci, including recently published findings ([@B8], [@B34]; [@B21]) and the work presented here, may eventually shed light on the past and present distributions of epidemiologically important pneumococcal serotypes.

General Genomic Features of Non-Pneumococcal Strains Carrying *cps* Loci Closely Similar to Serotype 5 Pneumococci
==================================================================================================================

Genome sequences of the 4 *wzy5*-positive isolates revealed that all lacked the pneumococcal-specific *piaA* iron transporter determinant ([@B36]). Sequence from strain F0392, for which only the genome sequence has been available but corresponding strain serology not characterized ([@B34]), is also included for comparison. Although negative for the pneumococcal *lytA* PCR assay [@B9] Strain KE67013 contained recognizable homologs of the major pneumococcal autolysin (*lytA*) and of the pneumolysin gene (*ply*), with 79 and 60% sequence identity, respectively. Strain F0392 contained a *lytA* homolog (72% identity), while strains US0049, US969j1, and US0024h lacked recognizable homologs of all three genes.

Phylogenetic analysis employing kSNP3.0 ([@B13]) revealed that the five *wzy5*-positive strains \[including strain F0392 ([@B34])\] were genetically highly diverse, clustering with representatives of *S. infantis*, *S. mitis*, and *S. oralis* clusters (Figure [1A](#F1){ref-type="fig"}). Phylogenetic analysis employing concatenated housekeeping gene fragments as previously described ([@B5]) was in close agreement with the depicted whole genomic kSNP.0 analysis (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). For the non-study strains depicted in Figure [1A](#F1){ref-type="fig"}, kSNP3.0 analysis (Figure [1A](#F1){ref-type="fig"}) was also generally in agreement with their previous genomic-based species assignments ([@B18]).

![**(A)** Maximum parsimony tree based upon kSNP3.0 analysis ([@B13]) of eight study genomes (indicated in red including *wzy* or *wzx* genes initially detected in PCR-serotyping assay) from this study, combined with 66 genomes from GenBank within the species *S. mitis*, *S. oralis*, and *S. infantis* described previously ([@B18]). The k-mer size employed was 19. The scale is based upon 322 core SNPs. The indicated node support values were calculated by FastTreeMP as described ([@B13]). The genome from strain F0392 obtained from NCBI (indicated in green) is also included. **(B)** Alignments of *cps5* operons from five strains of non-pneumococcal species *S. mitis* (SM) 67013, *S. oralis* (SO, strains US0049 and F0392), and *S. infantis* (SI; strains US969j1 and US0024). The percent sequence identity of the entire biosynthetic cluster (*wzg* through *fnlC*) with the pneumococcal serotype 5 reference sequence (GenBank accession CR931637) is underlined at left. The percent identity of the allele over its entire overlap with the pneumococcal reference is indicated within each rectangle representing the indicated gene. For the *S. oralis* and *S. infantis* alignments that each depict a pair of distinct strains, each gene has the indicated conserved translational start and/or end. *S. mitis* 67013 is the only strain showing close linkage of the *cps5* locus with upstream *pbp2x* and downstream *pbp1a*, while the two *S. oralis cps5* loci lie 2--17 kb upstream of *pbp1a*. The position of conventional (c) and real time (rt) serotype 5 detection assays are indicated (c assay positive for all four strains tested, rt assay positive for all but *S. mitis* US67013). The percent identities are indicated between the two pairs of strains (US0049/F0392 and US969j1/US0024) below the indicated genes. The five *cps5* genes that appear entirely serotype 5-specific ([\<]{.ul}54% identical to all other known pneumococcal *cps* genes) are indicated in orange. Phylogenetic analysis shows the relative relatedness of the five serotype 5 specific genes between the four species. Gene functions listed at bottom left are taken from accession CR931637. Black rectangles indicate transposase gene remnants. The orientations of *pbp2x* and *pbp1a* relative to *cps5* are indicated at the right and left end, respectively, of each *cps5* operon. The coordinates above the genes indicate base pairs (bp), also indicated as distances between the *cps* loci and flanking *pbp* genes.](fmicb-09-03199-g001){#F1}

All five non-pneumococcal *wzy5*-positive strains contained *cps* loci highly similar to the corresponding *cps5* locus from the serotype 5 pneumococcal reference strain, with 87.3-- 90.5% sequence identity over the entire operon (Figure [1B](#F1){ref-type="fig"}). Highly homologous (78--99.2% sequence identity) counterparts of each of the previously described 15 *cps5* genes from the pneumococcal serotype 5 reference strain were apparent in the same relative order. The first four genes of the *cps5* locus (*wzg*, *wzh*, *wzd*, and *wze*) have widely conserved functions in pneumococcal capsular polysaccharide synthesis, corresponding with high similarity (\>98% sequence identity, regardless of serotype) to a large number of counterparts from pneumococcal *cps* operons ([@B24]). An additional 6 *cps5* genes with more specialized functions are conserved among a subset of pneumococcal serotypes (Figure [1B](#F1){ref-type="fig"}). The centrally situated five *cps5* genes, including the *wzy* and *wzx* genes that encode highly substrate-specific flippase and polymerase functions, share little or no sequence similarity with pneumococcal strains of other known capsular serotypes; however, these pneumococcal genes shared 76--99% sequence identity among the five non-pneumococcal strains shown. The highly conserved five-gene segment was exactly 5,429 bases in length in all six strains (including *S. pneumoniae* strain Ambrose) and shared the same spacings of translational start and stop codons.

The presence of the *fnlA-C* genes in serotype 5 (Figure [1B](#F1){ref-type="fig"}) is consistent with N-acetyl-α-L-fucosamine found within serotype 4, 5, 12A, and 12F capsule polysaccharides ([@B19]; [@B24]). Further, N-acetyl-L-pneumosamine and 4-keto-N-acetyle-D-quinovosamine, intermediates within the N-acetyl-α-L-fucosamine pathway, are both uniquely present in the pneumococcal serotype 5 capsule. As previously speculated ([@B24]), the marked sequence divergence of the *cps5 fnlA* gene compared to *fnlA* alleles of types 4, 12A, and 12F might be related to the unique final products produced in the *cps5* N-acetyl-α-L fucosamine pathway. The near-identical *fnlA* sequences of the five *wzy5*-positive commensal strains of the three different species and serotype 5 pneumococci are consistent with structural similarity or identity between the capsular polysaccharides (Figure [1B](#F1){ref-type="fig"}).

One or both of the *pbp2x* and *pbp1a* genes are sometimes co-transferred along with *cps* loci during pneumococcal gene replacement events ([@B6]; [@B37]). The location of *cps5* in the genome relative to *pbp1a* and *pbp2x* varied between the commensal strains (Figure [1B](#F1){ref-type="fig"}), although the *S. mitis cps5* locus showed the same orientation and relative genomic location between the upstream *pbp2x* and downstream *pbp1a* genes as the serotype 5 pneumococcal reference strain. The two *S. oralis cps5* loci were not closely linked to *pbp2x*, but linkage to the downstream convergent *pbp1a* gene was observed. Genomic proximity of *cps5* from the two *S. infantis* strains to *pbp2x* was also lacking, however, *cps5* from one of the two strains (US0024h) was situated 35 kb upstream of the convergent *pbp1a*. Due to the smaller length of the *cps5*-containing contig, we were unable to verify similar linkage of *cps5* from *S. infantis* US0969j1 to *pbp1a*.

As with pneumococcal *cps* loci, the *cps5* locus from *S. mitis* KE67013 and the two *S. oralis* strains were situated between *dexB* and *amiA*. The *cps5* loci from the two *S. infantis* strains isolated within the United States differed in their genomic location compared to the other three species in that it was situated immediately upstream of the cell division gene *ftsA* (not shown).

Shared Serospecificity of Non-Pneumococcal *cps5*-Carrying Strains With Serotype 5 *S. pneumoniae*
==================================================================================================

For unknown reasons we could not see a positive Quellung reaction for three of the four *cps5*-positive non-pneumococcal strains with pneumococcal typing serum specific for serotype 5, however, we could detect a subtle positive result for *cps5*-positive *S. mitis* strain KE67013 (data not shown). Immunodiffusion experiments demonstrated specific reactivity of each strain with anti-pneumococcal type 5 typing serum (Figure [2A,B](#F2){ref-type="fig"}).

![**(A)** Reactivity of typing antisera raised against serotype 5 pneumococcal strain Ambrose (middle well) against *wzy5*-positive strains of *S. infantis*, *S. oralis*, *S. mitis*, and serotype 5 *S. pneumoniae* Ambrose. A serotype 4 pneumococcal strain is included as a negative control. In other experiments pneumococcal serotype 1 and *S. mitis cps1*-positive strain L006 ([@B21]) were included as negative controls and showed no reactivity. **(B)** Top: Reactivity of pneumococcal serotype 5 typing antisera against *S. mitis* KE67013 (top grid, center well contains type 5 antisera; wells 1 and 2 contain type 5 pneumococcal extract. Wells 3 and 4 contain strain KE67013 extract. Middle and lower grids show reactivity of indicated dilutions of pneumococcal typing antisera (peripheral wells) against *S. mitis* KE67013 extract (middle grid, center well) and serotype 5 *S. pneumoniae* strain Ambrose extract (lower grid, center well). **(C)** Positive Quellung reactions of serotype 5 pneumococcal strain Ambrose when reacted with antisera raised against *wzy5*-positive *S. mitis* strain KE67013 (top panel) and with standard serotype 5 typing antiserum (middle panel). The same pneumococcal type 5 strain showed no reactivity when exposed to antisera prepared against an *S. mitis* strain L006 containing a *cps1*-like operon ([@B21]) unrelated to *cps5* (bottom panel). **(D)** Opsonophagocytic killing (OPK) activity of rabbit antisera raised against serotype 5 *S. mitis* KE67013 in three separate rabbits (1--3) and of pooled, clarified antisera from the three rabbits (pooled). Geometric Mean Titer (GMT) values of titers across 5--6 assay runs are shown with \>50% killing compared with the growth in the complement control wells. Initial dilution was 1:400 with subsequent two-fold dilutions down to 1:51200. Test of the rabbit antiserum generated against serotype 5 *S. pneumoniae* gave optimal titer at 1:960 (not shown). KE67013 was included as the positive control in the OPK assay; KE67013 antiserum had very high (titer \> 3000) opsonic activity against strain KE67013 (not shown). Pre-inoculation bleeding samples for all rabbits induced no killing (data not shown). Antisera prepared against control strain of *S. mitis* L006 carrying a full-length *cps1*-like operon (strain and antiserum described in [@B21]) unrelated to *cps5* showed no OPK activity against serotype 5 pneumococci. Coefficient of variation (CV) = standard deviation/GMT;SE (*σ*) = GMT ^∗^ (exp (standard deviation) -- 1)/sqrt (N) $\sigma = \sqrt{\frac{1}{N}\sum\limits_{i = 1}^{N}\left( {X_{i} - \mu} \right)^{2}.}$ Where, *x~i~* is an individual natural-log transformed value *μ* is the mean/expected value and *N* is the total number of values. $\text{CV} = \sqrt{e^{\sigma^{2}} - 1}.$](fmicb-09-03199-g002){#F2}

In addition, antiserum produced against strain KE67013, the strain which yielded the weakest immunodiffusion results with anti-pneumococcal type 5 serum (Figure [2A](#F2){ref-type="fig"}), exhibited strong specific reactivity with pneumococcal serotype 5 strains in immunodiffusion (not shown) and in the Quellung reaction (Figure [2C](#F2){ref-type="fig"}).

This same antiserum raised against strain KE67013 was highly and specifically active in opsonophagocytosis killing (OPK) assays directed against serotype 5 pneumococci (Figure [2D](#F2){ref-type="fig"}), and showed no OPK activity against pneumococci of serotypes 1 and 4 (data not shown). The OPK activity of 3 of the 4 antiserum samples (1st, 3rd, and pooled depicted in Figure [2D](#F2){ref-type="fig"}) against serotype 5 *S. pneumoniae* was actually higher than our typing antisera prepared against type 5 *S. pneumoniae* (Figure [2D](#F2){ref-type="fig"}). Additionally, antisera prepared against a control strain of *S. mitis* carrying a full-length *cps1*-like operon (strain and antiserum described in [@B21]) unrelated to *cps5* showed no OPK activity against serotype 5 pneumococci.

Genetic and Serologic Features of Other Non-Pneumococcal Strains With Additional Pneumococcal-Like *cps* Loci
=============================================================================================================

Included in Figure [1A](#F1){ref-type="fig"} and Table [1](#T1){ref-type="table"} are non-pneumococcal strains recovered in samples from the same Kenya study ([@B8]) that were PCR-positive for pneumococcal serotypes other than serotype 5 and were assigned non-pneumococcal species based upon housekeeping gene sequence phylogeny ([@B5], Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}) and WGS-based phylogeny (Figure [1A](#F1){ref-type="fig"}). These serogroups included 18 (assigned as *S. mitis* KE66713), 15A/15F (*S. oralis* KE66813), 33 (*S. oralis* KE66913, and 12 (*S. oralis* KE67213). When comparing the genomic locations of *cps* operons from *S. mitis* (*cps18*) and *S. oralis* (*cps15A*, *cps33F*, and *cps12F*) with *cps* loci highly similar to those found in pneumococci of the same specific serotypes (Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}), only *cps18* from *S. mitis* KE66713 showed close linkage to both *pbp2x* and *pbp1a* (data not shown). *S. mitis* KE66713 (*cps18*) was the only commensal isolate described here that was from a child and was recovered from a nasopharyngeal specimen ([@B8]).

Immunodiffusion experiments showed specific reactivity of *S. mitis* strain KE66713 indicative of being weakly positive for serotype 18A (reactivity with serotyping factor 18d). *S. oralis* KE66913 (*cps33*) showed pool E reactivity (pool E consists of all factors for resolution of serogroups 12 and 33, along with serotypes 13, 44, and 46) which could only be narrowed to very weak serogroup 33 reactivity. Similarly, KE67213 (*cps12*) demonstrated strong reactivity with pool E, but the reactivity could only be narrowed to serogroup 12, due to no reactivity with individual serogroup 12 factors. We did not observe detectable *S. oralis* strain KE66813 (*cps15A*) reactivity with pneumococcal serogroup 15 antiserum.

Resistance Features Found Within Non-Pneumococcal Strains Carrying *cps* Locus Homologs of Known Pneumococcal *cps* Loci
========================================================================================================================

It was interesting to find that six of the seven non-pneumococcal strains included within this study and all five of the cps1-positive *S. mitis* strains from the previous study were non-susceptible to one or more antibiotics, with these resistance features corresponding to determinants detected through our pneumococcal WGS bioinformatics pipeline (Table [2](#T2){ref-type="table"}). Nine of the 13 isolates were non-susceptible to one or both of the beta lactam antibiotics penicillin or ceftriaxone. It was interesting that the pneumococcal PBP typing scheme identified one of five new PBP types ([@B25]) for six of the seven *S. mitis* strains. For all other strains, 1--2 of the 3 PBP subtypes were not generated since they carried divergent PBP gene alleles that were not identifiable within the current pipeline parameters. All seven of the PBP typed *S. mitis* strains that carried one of five new PBP types. Conventionally determined MICs for penicillin and ceftriaxone were in close agreement with a machine learning based algorithm that predicts beta lactam MICs for new PBP types ([@B22]). Two highly related *cps1*-positive *S. mitis* isolates (L115 and L116) shared the same PBP types that included a penicillin binding protein subtype (2*x* -- 8) commonly found within multiple penicillin-non-susceptible pneumococcal clones ([@B3]). Six isolates carried macrolide resistance determinants (*mef/msrD* and/or *ermB*) that correlated to observed resistance for erythromycin and/or clindamycin. Eight isolates carried mutations within *folA* and/or *folP* genes that correlated to intermediate resistance (1--2 μg/ml) or full resistance ([\>]{.ul}4 μg/ml) to cotrimoxazole. Seven isolates contained *tetM* derivatives also predicting non-susceptibility to tetracycline. All three isolates that were susceptible to beta lactam antibiotics would not be considered to be basally susceptible as defined for basally susceptible pneumococci which uniformly have MICs [\<]{.ul} 0.03 μg/ml for both penicillin and ceftriaxone.

###### 

Pneumococcal resistance features^A^ found within non-pneumococcal strains carrying homologs of pneumococcal *cps* loci.

  Non-pneumococcal                                                                                                            
  ------------------ --------------- -------- -------- -------------------------------------------- ------- -------- -------- --------
  KE67013 (5)        *S. mitis*      =0.5     = 0.25   FolA(I100L)/FolPins181, *tetM*               ≤0.03   ≤ 0.03   =4       \> 8
  US0049 (5)         *S. oralis*     ≤0.03    = 0.12   negative                                     ≤0.03   ≤ 0.03   ≤0.12    ≤ 0.25
  US0024 (5)         *S. infantis*   =0.5     =0.5     *mef/msrD*                                   =2      ≤0.03    ≤ 0.12   = 0.5
  US969j1 (5)        *S. infantis*   = 0.06   = 0.06   negative                                     ≤0.03   ≤ 0.03   = 0.25   = 0.5
  KE67213 (12)       *S. oralis*     =0.25    = 0.25   FolA(I100L), *tetM*                          ≤0.03   ≤ 0.03   =2       = 4
  KE66813 (15A/F)    *S. oralis*     =0.5     =0.5     FolA(I100L)                                  ≤0.03   = 0.06   =4       = 0.5
  KE66913 (33)       *S. oralis*     = 0.06   = 0.12   FolA(I100L)                                  ≤0.03   ≤ 0.03   =4       = 0.5
  KE66713 (18)       *S. mitis*      =0.12    = 0.12   FolA(I100L)/FolPins181                       ≤0.03   ≤ 0.03   =4       = 0.5
  L006 (1)^C,D^      *S. mitis*      =1       =1       *ermB*, FolA (I100L), *tetM*                 \> 32   \> 2     =4       = 4
  L164 (1)^C,D^      *S. mitis*      =2       =1       *ermB*, FolA (I100L), *tetM*                 \> 32   \> 2     =2       = 8
  L115 (1)^C,D^      *S. mitis*      =2       =1       *mef/msrD*, FolA(I100L)/FolPins178, *tetM*   = 4     ≤0.03    =4       \> 8
  L116 (1)^C,D^      *S. mitis*      =2       =1       *mef/msrD*, FolA(I100L)/FolPins178, *tetM*   = 4     ≤0.03    =4       \> 8
  L121 (1)^C^        *S. mitis*      =0.12    = 0.06   *ermB, mef/msrD, tetM*                       \> 32   \> 2     ≤0.12    \> 8

A

WGS pipeline features and abbreviations of resistance determinants as described (

Metcalf et al., 2016a

,

b

).

B

Minimum inhibitory concentrations determined conventionally and MICs indicated in red are indicative for non-susceptibility within pneumococci according to previously described parameters (

Metcalf et al., 2016a

). pen, penicillin; ery, erythromycin; cli, clindamycin; cot, cotrimoxazole; tet, tetracycline.

C

These five strains have been previously described (

Lessa et al., 2018

) and include two separate pairs of highly related strains (each indicated in blue or green font). These strains were recovered from the same US carriage study as strains US0049, US0024, and US969j1 that are included in this study and table.

D

The two highly related isolates L115 and L116 shared identical PBP types with both contained penicillin binding protein subtype PBP2X-8 commonly found within penicillin-non-susceptible pneumococci (

Metcalf et al., 2016b

;

Beall et al., 2018

). Highly related strains L006 and L164 shared 2 of the 3 PBP subtypes that define the PBP type. Of the 7

S. mitis

included, only L121 did not yield an identifiable PBP type through the pneumococcal WGS resistance pipeline

.

Discussion
==========

What is known about directionality of interspecies horizontal gene transfer between pneumococci and other Mitis group streptococcal species has shown that most observed transfer has been from commensal species donors to pneumococcal recipients ([@B12]; [@B33]; [@B20]). Much of this directionality has been shown through sequences of resistance-conferring PBP gene alleles, which invariably reveal that resistant pneumococcal clinical and carriage isolates contain PBP gene sequences that had their origins within non-pneumococcal Mitis group streptococci that are generally either *S. mitis* or *S. oralis* ([@B12]; [@B33]). This could be causally related to the higher abundance and longer carriage duration of commensal Mitis group species within the human host compared to pneumococcal strains, providing a vast commensal Mitis group donor gene pool. While we believe that it would not be surprising if non-pneumococcal species have been the source of individual serotype-specific *cps* genes ([@B20]), we believe that it is presently difficult to formally prove their origins based upon the paucity of individual sequenced serotype-specific alleles from commensal species. There is a very high level of genetic diversity observed between the non-pneumococcal species and/or strains carrying *cps5*-like loci \[the 4 strains (3 species) described in this work and the type 5 *S. oralis* genome from [@B34]\] and *cps1* loci \[3 unrelated clones (5 isolates) of *S. mitis* described by [@B21]\]. In view of present available data, serotype 1 and serotype 5 specific genes may well have been transferred from pneumococci to Mitis group species, or even have been derived from an undiscovered or extinct species ([@B21]). In pneumococci, two of the three key PBP genes closely flank the *cps* locus. Therefore, it is not surprising that *pbp2x* and *pbp1a* alleles have often been found to be co-transferred during recombinational *cps* locus replacement events ([@B6]; [@B37]; [@B26]; [@B3]). In general, however, the intraspecies conservation of pneumococci *cps* loci combined with the relative conservation of non-PBP genes flanking pneumococcal *cps* loci transferred during serotype-switch events (unpublished and GenBank data) seems to indicate that commensal species rarely serve as genetic donors of *cps* loci found within disease-causing pneumococcal strains.

From recent observations ([@B8]; [@B34]; [@B21]) and what we have observed here from a limited sampling of recently isolated naturally occurring commensal streptococci, the extent of highly conserved capsular biosynthetic loci shared between the global pathogen *S. pneumoniae* and other related members of the streptococcal Mitis group is far-reaching. Conjugate vaccines targeting pneumococcal serotypes decreases colonization of vaccine serotype pneumococci in the upper respiratory tract, and studies indicate that pneumococci have decreased expression of capsule during carriage relative to infection ([@B15]). Very little is known regarding the extent of expression of capsular polysaccharides by related non-pneumococcal species. Serotype 5 invasive disease has been rare in the United States even before the introduction of conjugate vaccines ([@B28]). The relative rarity of pneumococcal type 5 strains in previous carriage studies undertaken in Kenya ([@B10]) and in the United States ([@B32]; [@B11]), could be reflective of cross-species immunity conferred through the expression of capsule from commonly carried commensal serotype 5 strains of at least three different species in the upper respiratory tract. This possibility is speculative and requires additional studies, including those that assess specific immunologic responses from carriers of serotype 5 commensal streptococci. There are other potential reasons for the scarcity of serotype 1 and 5 strains causing disease within the past several decades. Pneumococci of both serotypes 1 and 5 are quite clonally restricted and are generally susceptible to antimicrobial agents, with extreme susceptibility to beta lactam antibiotics. It is possible that the broad usage of penicillin and other antibiotics in the later part of the 20th century played significant roles in the marked decrease of both serotypes, both of which were responsible for a heavy disease burden in the United States earlier in the century ([@B17]). The five serotype 1 and three of the serotype 5 non-pneumococcal strains examined here had more resistance determinants and higher MICs to different antibiotics than typical pneumococcal isolates of these same serotypes recovered from different geographic regions ([@B16]; [@B31]; [@B2]; [@B25]; [@B35]). These resistance features, including higher MICs to beta lactams, are likely to provide an advantage for their persistence within the upper respiratory tract carriage reservoir relative to pneumococcal strains of these same serotypes.

The findings that non-pneumococcal isolates of serotypes 1 and 5 are carried within the elderly US population at higher frequencies than pneumococci of these same serotypes presents a new landscape for the study of natural occurring pneumococcal immunity and serotype distributions ([@B8]; [@B21]). Similarly, it appears likely that serotype 5 *S. mitis* occurred within the Kenya carriage survey at a higher frequency than serotype 5 pneumococci ([@B8]; [@B10]). It will also be interesting to learn whether commensal strains of serotypes 1, 5 and other vaccine serotypes colonize different age groups with similar efficiencies within vaccinated and unvaccinated populations; in the previous sampling of older US adults, those who had received PCV13 were less likely than unvaccinated adults to be PCR-positive for genes specific for PCV13-serotypes within specimens PCR-negative for pneumococci ([@B21]).

Bacterial Strains
-----------------

Centers for Disease Control and Prevention (CDC) and local institutional review boards approved the studies (CDC protocol \#6725). The Kenya study was approved by ethics committees at the Kenya Medical Research Institute and CDC as described ([@B8]; [@B10]). Methods for isolation of the non-pneumococcal strains that were PCR-positive for serotype 5 and other known pneumococcal serotypes from upper respiratory specimens are as described ([@B8]). Conventional and real time PCR assays were previously described (9, 27) with updates posted at <https://www.cdc.gov/streplab/pneumococcus/resources.html>. The *cps5*-positive strains US0024, US969j1, and US0049 were recovered during this study from a stored US carriage study specimen collection ([@B21]). The genome sequence of strain F0392 was obtained from GenBank project accession AFUO01.

Genomic Sequencing
------------------

Genomic DNA samples from all isolates were prepared and sequenced as multiplexed libraries on the Illumina MiSeq platform to produce paired end reads ([@B26]).

Preparation of Streptococcal Antisera
-------------------------------------

This protocol (protocol number 2776GERRABC-A1) was approved by the Institutional Animal Care and Use Committee (IACUC). Antiserum against formalin-fixed *S. mitis* strain KE67013 was prepared exactly as previously described for CDC capsular typing antisera prepared against pneumococcal strains ([@B23]). Three rabbits were inoculated over a period of six weeks to yield the three antiserum sources used. A pooled, chloroform clarified sample that combined all three sources was also used.

Serology
--------

Latex agglutination and the Quellung reaction employing rabbit polyclonal typing antiserum were used to assess serotype expression in commensal streptococci. Double immunodiffusion assays employing pneumococcal typing sera and antisera prepared against commensal streptococci were carried out as previously described ([@B34]).

Species Assignments
-------------------

Strains were assigned species by virtue of clustering with previously speciated strains ([@B18]) employing whole genomic kSNP3.0 analysis to generate core genomic single-nucleotide polymorphism and a maximum parsimony phylogenetic tree with the indicated node support as described ([@B13]). Node support was assessed by using 500 bootstrap replicates. Phylogenetic clustering of concatenated housekeeping gene sequences (multilocus sequence analysis; MLSA) was achieved with the Mega7 program as previously described ([@B5]).

Opsonophagocytosis (OPK) Assays
-------------------------------

The standard OPK assay was performed employing HL-60 cells and complement source (baby rabbit serum; Pel-Freez, Brown Deer, Wis.) as outlined previously ([@B30]). Initial dilution was determined at 1:400 based on optimization testing with serotype 5 *S. pneumoniae*-induced antisera against type 5 *S. mitis* KE67013. Complement control wells included all the test reagents except antibodies to pneumococci. Opsonophagocytic titers taken for Geometric Mean Titer (GMT) reflect the serum dilution with \>50% killing compared with the mean growth in the complement control wells.

Genomic Fastq Accession Numbers
===============================

Accession numbers for [KE66713](KE66713)--[KE67213](KE67213), [US0024](US0024), [US0049](US0049), and [US969](US969) fastQ files are SAMN09874918 through SAMN9874925 within BioProject [PRJNA480039](PRJNA480039).

Note Added in Proof
===================

Genevieve Gariss and colleagues at the Karolinska Institutet have described an apparently serotype 5 strain of a fifth Mitis group species, *S. pseudopneumoniae*: see [10.1101/468462](https://doi.org/10.1101/468462).
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###### 

Assignment of study strains to species employing phylogenetic clustering of concatenated housekeeping genes as previously described ([@B5]). Where not labeled the sequences were obtained from this study and shared the same species clustering. Methodology follows this paper exactly, except that only the four closest species clusters to *S. pneumoniae* were included. Twenty pneumococcal strains of 10 different serotypes were included. Established reference strains with genomes accessible in public databases include the indicated pneumococcal strains, ATCC BAA960 and IS7493 (*S. pseudopneumoniae*); NCTC 12261, B6, and SK578 (*S. mitis*); ATCC 700779, SK1302 (*S. infantis*); and CCECT7747, UO5, SK313, SK141, OD321121-09 (*S. oralis*). The optimal tree with the sum of branch length = 5152.37943912 is shown. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances are in the units of the number of base differences per sequence. The analysis involved 136 nucleotide sequences. Codon positions included were 1st+2nd+3rd+Non-coding. There were a total of 3063 positions in the final dataset for each strain.

###### 

Click here for additional data file.

###### 

General features of additional homologs of *cps* loci from non-pneumococcal species (SO, *S. oralis*; SM, *S. mitis*) compared to pneumococci of known capsular serotypes. The genes aligned by the slanted lines indicate the polysaccharide synthetic gene cluster. Within each gene of the cluster, the percent identity between the two homologs is shown. In each *cps* operon shown the gene cluster lies between *dexB* and *aliA*. White rectangles indicate open reading frames (orfs) that lack homology with the respective pneumococcal reference sequence. The red lines indicate region targeted by conventional and real time "PCR-serotyping" assays. The orange open reading frames share [\>]{.ul}60% sequence identity only with pneumococcal strains within small serogroups as follows: **A**, 12F/12A/12B/44/46; **B**, 15A/15F; **C**, 18C/18A/18B/18F; **D**, 33F/33A/37. Black rectangles do not represent open reading frames, but have spurious homology to transposase structural genes. For descriptions of conserved and serotype-specific gene functions, see the indicated GenBank accessions for the pneumococcal reference serotypes as described ([@B4]; [@B1]; [@B24]). **(A)** Comparison of *S. oralis* KE67213 *cps12* polysaccharide biosynthetic locus with the 17 gene pneumococcal *cps12F*. KE672-13 has a single orf (bases 12726--14978) that corresponds to the distinct pneumococcal orfs *wcxD* and *wcxE* as indicated. Otherwise, the two polysaccharides share exactly the same gene order. **(B)** Comparison of *S. oralis* KE66813 polysaccharide biosynthetic gene cluster with the 16 gene pneumococcal *cps15A*. The *wciZ* contains frameshift and is lacking altogether in strain KE66813. Although KE66813 contains a gene with homology to *wchX* that encodes a putative glycerol phosphotransferase, strain KE66813 lacks the three glycerol-2-phosphate synthesis genes (*gtp1*, *gtp2*, *gtp3*). **(C)** Comparison of *S. mitis* KE667-13 ("*cps18"*) polysaccharide biosynthetic locus with pneumococcal *cps18C* (accession CR931673). The asterisk for the pneumococcal *glf* gene indicates that it is a pseudogene that contains several stop codons, even though it is of the same exact length as its highly homologous *S. mitis* counterpart that contains no stop codons. The open reading frame *orf1* is highly homologous to an open reading frame in *S. mitis* SK667 (accession JPV01000015) while *orf2* has limited homology to *wcyF* (unknown function) within the pneumococcal *cps25A*, *cps25F*, and *cps38* operons. **(D)** Comparison of *S. oralis* KE66913 ("*cps33*") polysaccharide biosynthetic gene cluster (orfs *wzg* through *glf*) with pneumococcal *cps33F* (GenBank accession CR931702). The open reading frame *wycO* (putative acetyltransferase) has indicated homology to the *cps21* homolog. Two full-length *aliB* (oligopeptide-binding protein) genes are indicated.

###### 

Click here for additional data file.
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